论文信息 - 638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease - 字舞流文

638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease

U. Kopylov | B. Bressler | G. Mantzaris | H. Patel | A. Yarur | D. Demuth | T. Lissoos | S. Saha | N. Brett | M. Bassel | A. Natsios | C. Lopez | C. Kifnidi